How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved
How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
Source link
메타데이터
- post_id
- 73740cd4e54d
- slug
- how-aduhelm-an-unproven-alzheimers-drug-got-approved-73740cd4e54d
- url
- https://medium.com/@digitalmarketing8989/how-aduhelm-an-unproven-alzheimers-drug-got-approved-73740cd4e54d
- canonical_url
- https://medium.com/@digitalmarketing8989/how-aduhelm-an-unproven-alzheimers-drug-got-approved-73740cd4e54d
- author_url
- https://medium.com/@digitalmarketing8989
- status
- ok
- fetched_at
- 2026-07-30 09:58:37
